Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
18.95
+0.48 (2.63%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $584.75 million as of April 23, 2025. Its market cap has decreased by -7.74% in one year.
Market Cap
584.75M
Enterprise Value
-233.40M
1-Year Change
-7.74%
Ranking
Category
Stock Price
$18.95
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $584.75M, an increase of 273.64%. That is a compound annual growth rate of 16.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 569.10M | 0.74% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.65B |
| UnitedHealth Group | 389.54B |
| Johnson & Johnson | 374.10B |
| AbbVie | 313.02B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.15B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |